A new polio vaccine to combat the debilitating disease may soon become a reality.
Scientists from Britain and the US are working on a synthetic vaccine that is currently being engineered at the University of Leeds.
The team hopes to create a vaccine that does not contain the viral genome but instead mimics the structure of the live virus. Such a vaccine would be quicker, easier and safer to produce.
"Using a combination of techniques, we've begun the task of gathering crystal structures and electron microscopy images that will tell us what we need to know to stabilise the shell of the virus and engineer a strong vaccine that has the ability to bring about the desired immune response in humans," said Dave Stuart, professor of structural biology at Oxford University.
Even after the apparent global elimination of poliomyelitis it will be necessary to continue vaccination as a precaution against re-introduction of the virus from hidden sources.
A synthetic vaccine would fulfil this role without the inherent danger of accidental release of virus associated with the production of current vaccines.
Eventually such vaccines could pave the way to completely eliminating the necessity to vaccinate.
"Early results with polio are very promising, with synthetic particles being produced and evidence of successful stabilisation," Stuart said while speaking at the American Association for the Advancement of Science meeting in San Jose recently.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
